Kymera Therapeutics Soars as Sanofi Expands Studies of Its Skin Diseases Drug
Kymera Therapeutics shares jumped Tuesday, a day after it said partner Sanofi agreed to expand research into its experimental treatment for skin diseases.
( 17
min )